Trial · NCT00094445
Trial of Curcumin in Advanced Pancreatic Cancer
NCT00094445, Phase 2, Completed, M.D. Anderson Cancer Center; results first posted 2020-08-28
3 sourcestrials-2026-11-12-0.5.0
Cite this record
ConductScience Library. Trial of Curcumin in Advanced Pancreatic Cancer. Trials, record NCT00094445. Release trials-2026-11-12-0.5.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT00094445
On this page
Trial
As registered on ClinicalTrials.gov, in the graph's capture of the registry.
- Title
- Trial of Curcumin in Advanced Pancreatic Cancer
- NCT number
- NCT00094445
- Status
- Completed
- Phases
- Phase 2
- Enrollment
- 50 participants, actual
- Lead sponsor
- M.D. Anderson Cancer Center
- Conditions
- Pancreatic Neoplasms, Adenocarcinoma
- Interventions
- Curcumin
- First posted
- 2004-10-19
- Last updated
- 2020-08-28
- Results first posted
- 2020-08-28
Source ClinicalTrials.gov
Registered outcomes1
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | Six-Month Participant Survival | Baseline to 6 months | Number of participants followed from baseline (date of randomization) until the date of first documented progression or date of death from any cause, whichever came first, assessed up to 6 months. |
Source ClinicalTrials.gov
Outcomes1
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
| Type | Outcome | Time frame | Population | Units | Measured as |
|---|---|---|---|---|---|
| PRIMARY | Six-Month Participant Survival | Baseline to 6 months | Participants | COUNT_OF_PARTICIPANTS |
Source ClinicalTrials.gov
Results by group1
Each measurement the trial posted, group by group, in the words and numbers it posted.
| Outcome | Group | Category | Value | Spread | Units |
|---|---|---|---|---|---|
| Six-Month Participant Survival | Curcumin | 7 | Participants |
Source ClinicalTrials.gov
Participant flow3
How many started, completed or left each group, period by period.
| Period | Milestone | Group | Participants | Units counted |
|---|---|---|---|---|
| Overall Study | STARTED | Curcumin | 50 | |
| Overall Study | COMPLETED | Curcumin | 44 | |
| Overall Study | NOT COMPLETED | Curcumin | 6 |
Source ClinicalTrials.gov
Adverse events31
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
| Type | Event | Organ system | Group | Affected | At risk | Events |
|---|---|---|---|---|---|---|
| other | edema | Skin and subcutaneous tissue disorders | Curcumin | 4 | 44 | |
| other | vomiting | Gastrointestinal disorders | Curcumin | 2 | 44 | |
| other | nausea | Gastrointestinal disorders | Curcumin | 2 | 44 | |
| other | abdomen | Gastrointestinal disorders | Curcumin | 1 | 44 | |
| other | depression | Nervous system disorders | Curcumin | 1 | 44 | |
| other | Fatigue | General disorders | Curcumin | 1 | 44 | |
| serious | GI hemmorhage | Gastrointestinal disorders | Curcumin | 1 | 44 | |
| serious | Chest pain | Cardiac disorders | Curcumin | 1 | 44 | |
| serious | Multiple pulmonary emboli | Cardiac disorders | Curcumin | 1 | 44 | |
| serious | chronic cancer progression | Gastrointestinal disorders | Curcumin | 1 | 44 |
1 to 10 of 31Source ClinicalTrials.gov
See all 31 adverse eventsAdverse event totals3
The totals the trial posted for each group.
| Total | Group | Affected | At risk |
|---|---|---|---|
| Total, all-cause mortality | Curcumin | ||
| Total, other adverse events | Curcumin | 6 | 44 |
| Total, serious adverse events | Curcumin | 9 | 44 |
Source ClinicalTrials.gov
Papers1
The papers the trial lists on ClinicalTrials.gov.
| PMID | Listed as |
|---|---|
| 12680238 | BACKGROUND |
Source PubMed
Grants1
The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.
| Project | Title | Principal investigators | Organization | Funder | Fiscal years |
|---|---|---|---|---|---|
| R21CA104337 | Exploratory Trial of Curcumin in Pancreatic Cancer | KURZROCK, RAZELLE | UNIVERSITY OF TEXAS MD ANDERSON CAN CTR | NATIONAL CANCER INSTITUTE | 2004 to 2005 |
Source NIH RePORTER
Trial comparisons0
Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.
None in this release.
Tests0
The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.
None in this release.
Data dates
The day each source was copied for this release.
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this trial from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/trials/v1/NCT00094445
GET https://conductscience.org/api/trials/v1/NCT00094445/events?page=2